Clinical trials
Gastrointestinal Neoplasms trials in France with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
23 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2014 | 2 |
| 2016 | 1 |
| 2017 | 1 |
| 2019 | 2 |
| 2021 | 5 |
| 2022 | 1 |
| 2023 | 4 |
| 2024 | 1 |
| 2025 | 1 |
| 2026 | 5 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 9 |
| Completed | 5 |
| Not yet recruiting | 3 |
| Unknown status | 3 |
| Withdrawn | 2 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Assistance Publique - Hôpitaux de Paris | 3 |
| University Hospital, Strasbourg, France | 2 |
| Assistance Publique Hopitaux De Marseille | 1 |
| Centre Georges Francois Leclerc | 1 |
| Centre Hospitalier Universitaire de Besancon | 1 |
| Centre Hospitalier Universitaire de Nīmes | 1 |
| Centre Oscar Lambret | 1 |
| Centre Paul Strauss | 1 |
| Fondation Hôpital Saint-Joseph | 1 |
| GERCOR - Multidisciplinary Oncology Cooperative Group | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Gastrointestinal Neoplasms | 23 |
| Breast Neoplasms | 3 |
| Neoplasms | 3 |
| Malnutrition | 2 |
| Adenomatous Polyposis Coli | 1 |
| Carcinoma, Hepatocellular | 1 |
| Colitis, Ulcerative | 1 |
| Colorectal Neoplasms | 1 |
| Crohn Disease | 1 |
| Digestive System Diseases | 1 |
Trials
Showing 1 to 23 of 23. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.